Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Autor: | Mikael Cohen, Anne Lepine, Françoise Durand-Dubief, Bertrand Audoin, Mar Tintoré, Eric Thouvenot, Jonathan Ciron, Romain Marignier, Anne Ruiz, Kumaran Deiva, Jérôme De Seze, Philippe Horello, Alvaro Cobo-Calvo, Alexis Montcuquet, Caroline Papeix, Hélène Zéphir, Romain Deschamps, Sandra Vukusic, Hélène Maurey, Nicolas Collongues, Elisabeth Maillart, Pierre Labauge, Bertrand Bourre, Pierre Meyer, Damien Biotti, Georgina Arrambide, Fabien Rollot, Xavier Ayrignac |
---|---|
Přispěvatelé: | Neurological Hospital Pierre Wertheimer, Vall d'Hebron University Hospital [Barcelona], Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Fondation Eugène Devic EDMUS, Hôpital de la Fondation Ophtalmologique Adolphe de Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de Neurosciences de la Timone (INT), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service de pédiatrie spécialisée et médecine infantile (neurologie, pneumologie, maladies héréditaires du métabolisme) [Hôpital de la Timone - APHM], Hôpital de la Timone [CHU - APHM] (TIMONE), Service de neurologie [Le Kremlin Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Département Neurologie [CHU Toulouse], Pôle Neurosciences [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CIC, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France, Département de neurologie [Montpellier], Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Gui de Chauliac [CHU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université de Montpellier (UM), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service de Neurologie [CHU Nimes] (Pôle NIRR), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Service de neurologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Service de Neurologie [CHU Limoges], CHU Limoges, Service de Neurologie [CHU Nice], Hôpital Pasteur [Nice] (CHU)-Centre Hospitalier Universitaire de Nice (CHU Nice), Immunologie des Maladies Virales et Autoimmunes (IMVA - U1184), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Clinical Investigation Center, Inserm U1434, university hospital of Strasbourg, Hospices Civils de Lyon, Departement de Neurologie (HCL) |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Male 0301 basic medicine medicine.medical_specialty Optic Neuritis Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] Adolescent [SDV]Life Sciences [q-bio] Myelin oligodendrocyte glycoprotein Young Adult 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine Humans Medicine Optic neuritis Young adult 10. No inequality ComputingMilieux_MISCELLANEOUS Autoantibodies Aquaporin 4 Expanded Disability Status Scale biology business.industry Proportional hazards model [SCCO.NEUR]Cognitive science/Neuroscience Hazard ratio Age Factors medicine.disease Confidence interval 3. Good health 030104 developmental biology Neurology Chronic Disease Acute disseminated encephalomyelitis Disease Progression biology.protein Female Myelin-Oligodendrocyte Glycoprotein Neurology (clinical) business 030217 neurology & neurosurgery |
Zdroj: | Annals of Neurology Annals of Neurology, In press, 89, pp.30-41. ⟨10.1002/ana.25909⟩ Annals of Neurology, Wiley, In press, ⟨10.1002/ana.25909⟩ |
ISSN: | 0364-5134 1531-8249 |
DOI: | 10.1002/ana.25909⟩ |
Popis: | OBJECTIVE: The main objective was to compare clinical features, disease course, and myelin oligodendrocyte glycoprotein (MOG) antibody (Ab) dynamics between children and adults with MOG-Ab-associated disease (MOGAD). METHODS: This retrospective multicentric, national study included 98 children and 268 adults with MOGAD between January 2014 and September 2019. Cox regression model for recurrent time-to-event data and Kaplan-Meier curves for time to antibody negativity were performed for the objectives. RESULTS: Isolated optic neuritis was the most frequent clinical presentation in both children (40.8%) and adults (55.9%, p = 0.013), and acute disseminated encephalomyelitis syndrome was more frequent in children (36.7% vs 5.6%, p |
Databáze: | OpenAIRE |
Externí odkaz: |